Site icon Market Globalist

Why Cellect Biotechnology Ltd. (APOP) stock surged on Monday?

NIO Stock

NIO Stock

Cellect Biotechnology Ltd. (APOP) shares gained 6.84% in after-hours on Monday, August 30, 2021, and closed the daily trading at $5.31. In the regular trading session of Monday, APOP’s stock surged 18.62% as well. APOP shares have risen 111.49% over the last 12 months, and they have moved up 16.39% in the past week. Over the past three months, the stock has gained 51.99%, while over the past six months, it has declined 39.61%.

Let’s have a brief discussion about its latest news.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


>> 7 Top Picks for the Post-Pandemic Economy << 

APOP recent financial results announcement

On August 24, 2021, Cellect Biotechnology Ltd. (APOP) reported financial and operating results for the second quarter ended June 30, 2021.

Read More

Q2 2021 financial highlights

APOP Upcoming Special General Meeting

APOP has scheduled a Special General Meeting of Shareholders on September 19, 2021, to vote on the proposed strategic merger, and all shareholders and American Depositary Shareholders of Cellect Biotechnology Ltd. as of closed of business on August 19, 2021, are entitled to vote at the special meeting.

Background of APOP merger with Quoin

On June 16, 2021, Cellect Biotechnology Ltd (APOP) filed a registration statement, including a joint proxy statement/prospectus with the Securities and Exchange Commission (SEC) in connection with its proposed strategic merger with privately-held Quoin Pharmaceuticals. The transaction is currently expected to close in the 2021 third quarter.

SEC acknowledged the APOP merger

On August 13, 2021, Cellect Biotechnology Ltd. (APOP) announced that its registration statement filed on Form F-4 with the Securities and Exchange Commission on August 10, 2021, was declared effective by the SEC on August 12, 2021. Form F-4 was filed in connection with the previously announced strategic merger with Quoin Pharmaceuticals, Inc., a privately held U.S. based company focused on rare and orphan diseases.

The Company has scheduled a Special General Meeting of Shareholders for September 19, 2021, and anticipates closing the transaction by September 30, 2021.

>> 7 Top Picks for the Post-Pandemic Economy << 


Well, as of this writing, we have no reason to justify its gains on Monday and we are not sure how it will perform in the coming trading session.

Exit mobile version